Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Peptide Clinics Tennessee Providers Services 2026: Legal Comparison

Semaglutide (brand: Ozempic, Wegovy) FDA-approved as finished drug product Any Tennessee-licensed MD, DO, NP, PA with prescribing authority Retail pharmacy or 503B facility Yes. Synchronous audio-visual required Fully compliant. Standard telemedicine applies.

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Semaglutide (brand: Ozempic, Wegovy)
  • FDA-approved as finished drug product
  • Any Tennessee-licensed MD, DO, NP, PA with prescribing authority
  • Retail pharmacy or 503B facility
  • Yes. Synchronous audio-visual required
  • Fully compliant. Standard telemedicine applies. No regulatory ambiguity.
  • Compounded semaglutide
  • Active ingredient FDA-approved; compounded formulation is not
  • Same as above; shortage declaration allows 503B compounding
  • 503B outsourcing facility only (state compounding pharmacies cannot compound during non-shortage periods)
  • Compliant under shortage exemption. Legal status reverts if FDA removes semaglutide from shortage list.
  • Sermorelin
  • FDA-approved for pediatric GH deficiency; off-label adult use common
  • Tennessee-licensed prescriber; off-label use at prescriber discretion
  • State-licensed compounding pharmacy or 503B facility
  • Yes. No controlled substance restrictions
  • Compliant. Off-label prescribing is legal. Insurance rarely covers.
  • BPC-157, Thymalin, Epithalon
  • No FDA approval; sold as research chemicals
  • Not legally prescribable in Tennessee (no approved drug status)
  • Research chemical suppliers (not pharmacies)
  • No. Cannot be prescribed via telemedicine or in-person
  • Non-compliant. Purchasing these as 'prescriptions' violates Tennessee pharmacy law.
  • Tirzepatide (brand: Mounjaro)
  • FDA-approved for type 2 diabetes; off-label weight loss
  • Same as semaglutide
  • Fully compliant. Compounded versions available under shortage declaration.
  • CJC-1295
  • No FDA approval
  • Tennessee-licensed prescriber; compounding pharmacy at discretion
  • State-licensed compounding pharmacy (503B facilities typically decline)
  • Yes. If prescriber deems remote evaluation sufficient
  • Grey area. Legal if compounded by licensed pharmacy, but most 503B facilities refuse non-approved compounds.

Related resources

More comparisons